Division of Infectious Diseases, Washington University in St Louis School of Medicine, St Louis, Missouri, USA.
Division of Emergency Medicine, Washington University in St Louis School of Medicine, St Louis, Missouri, USA.
Clin Infect Dis. 2020 Dec 17;71(10):e650-e656. doi: 10.1093/cid/ciaa365.
Persons who inject drugs (PWID) are at risk of invasive infections; however, hospitalizations to treat these infections are frequently complicated by against medical advice (AMA) discharges. This study compared outcomes among PWID who (1) completed a full course of inpatient intravenous (IV) antibiotics, (2) received a partial course of IV antibiotics but were not prescribed any antibiotics on AMA discharge, and (3) received a partial course of IV antibiotics and were prescribed oral antibiotics on AMA discharge.
A retrospective, cohort study of PWID aged ≥18 years admitted to a tertiary referral center between 01/2016 and 07/2019, who received an infectious diseases consultation for an invasive bacterial or fungal infection.
293 PWID were included in the study. 90-day all-cause readmission rates were highest among PWID who did not receive oral antibiotic therapy on AMA discharge (n = 46, 68.7%), compared with inpatient IV (n = 43, 31.5%) and partial oral (n = 27, 32.5%) antibiotics. In a multivariate analysis, 90-day readmission risk was higher among PWID who did not receive oral antibiotic therapy on AMA discharge (adjusted hazard ratio [aHR], 2.32; 95% confidence interval [CI], 1.41-3.82) and not different among PWID prescribed oral antibiotic therapy on AMA discharge (aHR, .99; 95% CI, .62-1.62). Surgical source control (aHR, .57; 95% CI, .37-.87) and addiction medicine consultation (aHR, .57; 95% CI, .38-.86) were both associated with reduced readmissions.
Our single-center study suggests access to oral antibiotic therapy for PWID who cannot complete prolonged inpatient IV antibiotic courses is beneficial.
注射毒品者(PWID)存在侵袭性感染的风险;然而,这些感染的住院治疗常常因反对医嘱(AMA)出院而变得复杂。本研究比较了以下三类 PWID 的治疗结果:(1)完成了完整的住院静脉内(IV)抗生素疗程;(2)接受了部分 IV 抗生素疗程,但 AMA 出院时未开具任何抗生素;(3)接受了部分 IV 抗生素疗程,并在 AMA 出院时开具了口服抗生素。
这是一项回顾性队列研究,纳入了 2016 年 1 月至 2019 年 7 月在三级转诊中心住院、因侵袭性细菌或真菌感染接受传染病咨询的年龄≥18 岁的 PWID。
本研究共纳入 293 名 PWID。在未接受 AMA 出院时口服抗生素治疗的 PWID 中(n=46,68.7%),90 天全因再入院率最高,与接受住院 IV(n=43,31.5%)和部分口服(n=27,32.5%)抗生素治疗的 PWID 相比。多变量分析显示,未接受 AMA 出院时口服抗生素治疗的 PWID 90 天再入院风险更高(调整后的危险比[aHR],2.32;95%置信区间[CI],1.41-3.82),而接受 AMA 出院时口服抗生素治疗的 PWID 之间无差异(aHR,0.99;95% CI,0.62-1.62)。手术源控制(aHR,0.57;95% CI,0.37-0.87)和成瘾医学咨询(aHR,0.57;95% CI,0.38-0.86)均与降低再入院率相关。
我们的单中心研究表明,为无法完成长期住院 IV 抗生素疗程的 PWID 提供口服抗生素治疗是有益的。